StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the stock.
China Pharma Stock Performance
NYSE CPHI opened at $0.31 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.33 and a debt-to-equity ratio of 0.19. The business’s 50 day moving average is $0.38 and its two-hundred day moving average is $0.47. China Pharma has a 12-month low of $0.30 and a 12-month high of $2.70.
China Pharma Company Profile
See Also
- Five stocks we like better than China Pharma
- Trading Stocks: RSI and Why it’s Useful
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Breakout Stocks: What They Are and How to Identify Them
- Lockheed Martin Stock Aims for a Fresh All-Time High
- What Makes a Stock a Good Dividend Stock?
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.